Gilead Sciences
GILD
#129
Rank
NZ$260.36 B
Marketcap
NZ$209.83
Share price
-1.14%
Change (1 day)
35.16%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$101.32 Billion

According to Gilead Sciences's latest financial reports the company's total assets are NZ$101.32 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$104.60 B6.48%
2023-12-31NZ$98.23 B-1.27%
2022-12-31NZ$99.49 B0.01%
2021-12-31NZ$99.48 B4.93%
2020-12-31NZ$94.80 B3.61%
2019-12-31NZ$91.50 B-3.61%
2018-12-31NZ$94.92 B-4.08%
2017-12-31NZ$98.96 B20.31%
2016-12-31NZ$82.25 B8.86%
2015-12-31NZ$75.56 B70.79%
2014-12-31NZ$44.24 B61.02%
2013-12-31NZ$27.47 B6.42%
2012-12-31NZ$25.81 B16.46%
2011-12-31NZ$22.17 B47.54%
2010-12-31NZ$15.02 B12.53%
2009-12-31NZ$13.35 B11.71%
2008-12-31NZ$11.95 B56.93%
2007-12-31NZ$7.61 B31.34%
2006-12-31NZ$5.79 B5.25%
2005-12-31NZ$5.51 B82.37%
2004-12-31NZ$3.02 B26.33%
2003-12-31NZ$2.39 B-2.83%
2002-12-31NZ$2.46 B28.6%
2001-12-31NZ$1.91 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
NZ$156.03 B 54.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$43.03 B-57.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$231.77 B 128.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$10.69 B-89.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.55 B-50.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 256.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 229.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.95 B 96.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 121.32%๐Ÿ‡บ๐Ÿ‡ธ USA